{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T06:32:20Z","timestamp":1764225140988,"version":"3.40.4"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2012,11,14]],"date-time":"2012-11-14T00:00:00Z","timestamp":1352851200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0048992","type":"journal-article","created":{"date-parts":[[2012,11,14]],"date-time":"2012-11-14T22:57:39Z","timestamp":1352933859000},"page":"e48992","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cross-Species Functional Genomic Analysis Identifies Resistance Genes of the Histone Deacetylase Inhibitor Valproic Acid"],"prefix":"10.1371","volume":"7","author":[{"given":"Rakel Brendsdal","family":"Forthun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanima","family":"SenGupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne Kim","family":"Skjeldam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica Margareta","family":"Lindvall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmet","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f8rn Tore","family":"Gjertsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilde","family":"Nilsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,11,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc3130","article-title":"A decade of exploring the cancer epigenome - biological and translational implications","volume":"11","author":"SB Baylin","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrg3173","article-title":"Histone methylation: a dynamic mark in health, disease and inheritance","volume":"13","author":"EL Greer","year":"2012","journal-title":"Nat Rev Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrm3327","article-title":"Molecular mechanisms and potential functions of histone demethylases","volume":"13","author":"SM Kooistra","year":"2012","journal-title":"Nature reviews Molecular cell biology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/onc.2011.267","article-title":"Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy","volume":"31","author":"S Spiegel","year":"2012","journal-title":"Oncogene"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1517\/14728222.10.1.51","article-title":"Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML","volume":"10","author":"O Bruserud","year":"2006","journal-title":"Expert Opin Ther Targets"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/leu.2010.276","article-title":"Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia","volume":"25","author":"A Quintas-Cardama","year":"2011","journal-title":"Leukemia"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1182\/blood-2010-03-276485","article-title":"Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia","volume":"116","author":"H Kantarjian","year":"2010","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4161\/cbt.8.9.8118","article-title":"Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or raltitrexed","volume":"8","author":"E Di Gennaro","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.seizure.2010.01.014","article-title":"Long-term efficacy of valproate versus lamotrigine in treatment of idiopathic generalized epilepsies in children and adolescents","volume":"19","author":"M Mazurkiewicz-Beldzinska","year":"2010","journal-title":"Seizure"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/med.20027","article-title":"Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies","volume":"25","author":"RA Blaheta","year":"2005","journal-title":"Med Res Rev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.14712\/fb2007053020037","article-title":"Valproic acid, a molecular lead to multiple regulatory pathways","volume":"53","author":"M Kostrouchova","year":"2007","journal-title":"Folia Biol (Praha)"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","article-title":"Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors","volume":"34","author":"A Duenas-Gonzalez","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"ref13","first-page":"629","article-title":"Valproic acid and all-trans retinoic acid: meta-analysis of a palliative treatment regimen in AML and MDS patients","volume":"31","author":"F Bellos","year":"2008","journal-title":"Onkologie"},{"key":"ref14","first-page":"1529","article-title":"Functional characteristics and gene expression profiles of primary acute myeloid leukaemia cells identify patient subgroups that differ in susceptibility to histone deacetylase inhibitors","volume":"31","author":"C Stapnes","year":"2007","journal-title":"Int J Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"8903","DOI":"10.1158\/0008-5472.CAN-05-2726","article-title":"Sequential valproic acid\/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia","volume":"66","author":"G Cimino","year":"2006","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/leu.2011.315","article-title":"Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia","volume":"26","author":"E McCormack","year":"2012","journal-title":"Leukemia"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/j.seminoncol.2011.11.003","article-title":"Clinical applications of epigenetic markers and epigenetic profiling in myeloid malignancies","volume":"39","author":"MA McDevitt","year":"2012","journal-title":"Seminars in oncology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1182\/blood-2007-07-103242","article-title":"Abolition of stress-induced protein synthesis sensitizes leukemia cells to anthracycline-induced death","volume":"111","author":"G Gausdal","year":"2008","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1182\/blood-2007-10-119438","article-title":"Functional proteomic profiling of AML predicts response and survival","volume":"113","author":"SM Kornblau","year":"2009","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ccr.2009.08.018","article-title":"Proteomic and genetic approaches identify Syk as an AML target","volume":"16","author":"CK Hahn","year":"2009","journal-title":"Cancer Cell"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/B978-0-12-394620-1.00011-4","article-title":"Methods for studying the DNA damage response in the Caenorhabdatis elegans germ line","volume":"107","author":"AL Craig","year":"2012","journal-title":"Method Cell Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature01278","article-title":"Systematic functional analysis of the Caenorhabditis elegans genome using RNAi","volume":"421","author":"RS Kamath","year":"2003","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1091\/mbc.E09-08-0699","article-title":"Synthetic lethal genetic interactions that decrease somatic cell proliferation in Caenorhabditis elegans identify the alternative RFC CTF18 as a candidate cancer drug target","volume":"20","author":"J McLellan","year":"2009","journal-title":"Mol Biol Cell"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature10334","article-title":"RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia","volume":"478","author":"J Zuber","year":"2011","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1182\/blood-2011-07-367557","article-title":"RNAi screening of the kinome with cytarabine in leukemias","volume":"119","author":"R Tibes","year":"2012","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.exphem.2007.06.014","article-title":"Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response","volume":"35","author":"L Lagneaux","year":"2007","journal-title":"Exp Hematol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/pmic.200390006","article-title":"A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard","volume":"3","author":"A Alban","year":"2003","journal-title":"Proteomics"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/elps.200900780","article-title":"Temporal proteome profiling of taxol-induced mitotic arrest and apoptosis","volume":"31","author":"VH Bull","year":"2010","journal-title":"Electrophoresis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1534-5807(03)00327-7","article-title":"A conserved chromatin architecture marks and maintains the restricted germ cell lineage in worms and flies","volume":"5","author":"CE Schaner","year":"2003","journal-title":"Dev Cell"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","article-title":"p53 mutations in human cancers","volume":"253","author":"M Hollstein","year":"1991","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1476-4598-6-33","article-title":"Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells","volume":"6","author":"L Wergeland","year":"2007","journal-title":"Mol Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nature06145","article-title":"UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development","volume":"449","author":"K Agger","year":"2007","journal-title":"Nature"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1101\/gr.087528.108","article-title":"Global networks of functional coupling in eukaryotes from comprehensive data integration","volume":"19","author":"A Alexeyenko","year":"2009","journal-title":"Genome Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/nprot.2007.324","article-title":"Integration of biological networks and gene expression data using Cytoscape","volume":"2","author":"MS Cline","year":"2007","journal-title":"Nat Protoc"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1093\/bioinformatics\/bti551","article-title":"BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks","volume":"21","author":"S Maere","year":"2005","journal-title":"Bioinformatics"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/01635580903532416","article-title":"Lentinan: hematopoietic, immunological, and efficacy studies in a syngeneic model of acute myeloid leukemia","volume":"62","author":"E McCormack","year":"2010","journal-title":"Nutr Cancer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.leukres.2008.10.005","article-title":"A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid","volume":"33","author":"A Ryningen","year":"2009","journal-title":"Leuk Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1158\/0008-5472.CAN-04-2478","article-title":"Valproic acid alters chromatin structure by regulation of chromatin modulation proteins","volume":"65","author":"DC Marchion","year":"2005","journal-title":"Cancer Res"},{"key":"ref39","article-title":"Synergistic\/additive interaction of valproic acid with bortezomib on the proliferation and apoptosis of acute myeloid leukemia cells","author":"D Nie","year":"2012","journal-title":"Leukemia Lymphoma"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1011356623442","article-title":"Genes, chromatin, and breast cancer: an epigenetic tale","volume":"6","author":"LM Mielnicki","year":"2001","journal-title":"J Mammary Gland Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1073\/pnas.111409798","article-title":"A DAF-1-binding protein BRA-1 is a negative regulator of DAF-7 TGF-beta signaling","volume":"98","author":"K Morita","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/emboj.2009.180","article-title":"A histone code for the DNA damage response in mammalian cells?","volume":"28","author":"A Corpet","year":"2009","journal-title":"EMBO J"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ng.349","article-title":"Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer","volume":"41","author":"G van Haaften","year":"2009","journal-title":"Nat Genet"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2141.2009.07697.x","article-title":"Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia","volume":"145","author":"V Gelsi-Boyer","year":"2009","journal-title":"Br J Haematol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1101\/gad.1882610","article-title":"The histone demethylase UTX enables RB-dependent cell fate control","volume":"24","author":"JK Wang","year":"2010","journal-title":"Genes Dev"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"18439","DOI":"10.1073\/pnas.0707292104","article-title":"Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases","volume":"104","author":"S Hong","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations","volume":"141","author":"SV Sharma","year":"2010","journal-title":"Cell"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1038\/sj.onc.1208923","article-title":"Deregulated TGF-beta signaling in leukemogenesis","volume":"24","author":"HK Lin","year":"2005","journal-title":"Oncogene"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"35441","DOI":"10.1074\/jbc.M109.029488","article-title":"The phosphatidylinositol 3-kinase\/Akt pathway regulates transforming growth factor-{beta} signaling by destabilizing ski and inducing Smad7","volume":"284","author":"AM Band","year":"2009","journal-title":"J Biol Chem"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1158\/0008-5472.CAN-09-3143","article-title":"Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigens","volume":"70","author":"O Marina","year":"2010","journal-title":"Cancer Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ygyno.2007.06.023","article-title":"Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression","volume":"107","author":"D Koensgen","year":"2007","journal-title":"Gynecol Oncol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0048992","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T22:12:41Z","timestamp":1745187161000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0048992"}},"subtitle":[],"editor":[{"given":"Ivan Cruz","family":"Moura","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,11,14]]},"references-count":51,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0048992","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2012,11,14]]}}}